Clinical Trial Update: Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the combined use of teriparatide and raloxifene in postmenopausal osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Raloxifene (raloxifene)
• Teriparatide (Teriparatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis, Postmenopausal | Phase 3 | Status: COMPLETED